Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Eradicating TB is achievable but only if we show the same commitment that we did for COVID-19

March 29, 2021

Failure to meet commitments for TB research is not inevitable; the global COVID-19 response may show us the way.

Read more

Features

Uhambo: Twists and turns on the journey to an efficacious HIV-1 vaccine

March 24, 2021

IAVI CEO Mark Feinberg charts future HIV-1 vaccine development efforts in NEJM.

Read more

Features

Innovative bio-therapeutics for COVID-19: How can monoclonal antibodies for SARS-CoV-2 be made accessible in LMICs?

March 12, 2021

IAVI and partners recently held a webinar on challenges and opportunities for R&D of innovative biomedical treatments for COVID-19.

Read more

Features

International Women’s Day 2021

March 5, 2021

Spotlighting the work of IAVI’s female scientists and global advocates who work to ensure HIV prevention and care reaches adolescent girls and young women.

Read more

Features

Explainer videos: Understanding concepts of HIV vaccine development

February 12, 2021

Watch our explainer videos describing why we need an HIV vaccine, the vaccine development process, and the concept of vaccine-induced seropositivity.

Read more

Features

Prevention revolution or miles away from our targets? A look back at HIV Research for Prevention

February 9, 2021

Focus on access, innovation, communities, and partnerships, say leading voices.

Read more

Features

How can COVID-19 pave the way for global access pathways for monoclonal antibodies?

February 8, 2021

On January 19, IAVI co-convened a webinar with Wellcome and Unitaid on how COVID-19 may pave the way for global access to monoclonal antibodies.

Read more

Features

Evolving access pathways for long-acting HIV prevention products

February 3, 2021

Exploring potential bottlenecks and providing recommendations to accelerate access to future HIV prevention products.

Read more